Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

@article{Canavan2006MetaanalysisCA,
  title={Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease},
  author={C. Canavan and Keith R Abrams and John Francis Mayberry},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2006},
  volume={23}
}
Background  Crohn's disease is associated with small bowel cancer whilst risk of colorectal cancer is less clear. 
Review article: optimal preparation for surgery in Crohn's disease
TLDR
One‐third of Crohn's disease patients will undergo abdominal surgery within the first 5 years of diagnosis, according to the World Health Organization.
Patients’ knowledge and fear of colorectal cancer risk in inflammatory bowel disease
TLDR
To investigate knowledge and fear of colorectal cancer (CRC) risk in inflammatory bowel disease (IBD) patients, a large number of patients with a history of IBD or Crohn's disease are surveyed.
A matched case‐control study of IBD‐associated colorectal cancer: IBD portends worse outcome
TLDR
This clinical trial aims to evaluate oncologic outcomes of patients with IBD‐associated CRC by evaluating the effect of inflammatory bowel disease on outcome in patients with colorectal cancer.
Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice
Physician adherence to guidelines for colorectal cancer (CRC) surveillance in inflammatory bowel disease (IBD) is often poor. This may lead to adverse patient outcomes and excess endoscopic workload.
Cancer risk in Japanese Crohn's disease patients: Investigation of the standardized incidence ratio
There have been very few reported investigations on the standardized incidence ratio (SIR) of intestinal cancer and all cancers other than intestinal cancer with Crohn's disease (CD) by organ in
Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel disease
TLDR
This paper aims to determine whether there are differences in surgical and oncological outcomes following treatment for IBD‐CRC and SCRC.
Crohn's Disease and the Risk of Cancer.
  • E. Carchman
  • Medicine
    Clinics in colon and rectal surgery
  • 2019
TLDR
The current literature regarding Crohn's disease and subsequent risk of cancer formation is reviewed and future investigations into the molecular mechanisms associated with Crohn-related malignancy will provide additional insight into carcinogenesis, potential for early intervention, and identification of at-risk patients.
Gastrointestinal neoplasia in patients with inflammatory bowel disease: Opportunities to enhance preventative strategies
TLDR
The role of chronic inflammation and other possible predictors of the development of CRC are examined, as well as factors such as psychological comorbidity and engagement in care are assessed.
The clinical course of Crohn’s disease in a Danish population‐based inception cohort with more than 50 years of follow‐up, 1962‐2017
TLDR
Few population‐based studies have investigated the long‐term prognosis of Crohn's disease (CD), and the results suggest that the prognosis for patients with this disease is poor over the long term.
...
...

References

SHOWING 1-10 OF 53 REFERENCES
Intestinal and extra‐intestinal cancer in Crohn's disease: follow‐up of a population‐based cohort in Copenhagen County, Denmark
Aim : To determine the long‐term risk of intestinal and extra‐intestinal malignancies in Crohn's disease patients in Copenhagen County, Denmark.
Malignancy in Crohn's disease.
In a series of 295 patients with Crohn's disease, observed malignancy of the gastrointestinal tract was in excess of expectation. The small intestine and the pancreas were the sites where the excess
Cancer risk in patients with inflammatory bowel disease
The objective of the current study was to determine the incidence of cancer among persons with inflammatory bowel disease (IBD) and to compare these incidence rates with those of the non‐IBD
The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review
TLDR
To quantify, through systematic review, the epidemiology and natural history of Crohn’s disease in North America, the natural history and epidemiology of the disease are quantified.
Inflammatory bowel disease: epidemiology and management in an English general practice population
Inflammatory bowel diseases have significant long‐term morbidity and healthcare resource consequences. Studies based on secondary care records may have underestimated the contribution of general
Malignancy in crohn's disease.
TLDR
Cancer morbidity has been evaluated in a series of 513 patients with Crohn's disease under long-term review between 1944-76 and there was no excess of tumours at any site outside the digestive system.
Malignancy in Crohn's disease.
TLDR
Cancer morbidity has been evaluated in a series of 513 patients with Crohn's disease under long-term review between 1944-76 and there was no excess of tumours at any site outside the digestive system.
Crohn's disease and cancer risk (Denmark)
TLDR
Only for small intestinal cancer was a significantly elevated risk found among these patients hospitalized with Crohn's disease, and it was not detectable in the overall risk estimate for colorectal cancer.
Intestinal cancer in patients with Crohn’s disease
TLDR
Cancer risk in CD and especially in Crohn’s colitis may still be underestimated and the value of colonoscopy as surveillance tool is questioned by the fact that in patients, carcinoma was diagnosed in some patients preoperatively by routine Colonoscopy.
...
...